4.6 Article

Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 87, Issue 7, Pages 684-692

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2016-313146

Keywords

-

Funding

  1. Turkish Scientific and Technical Research Council [214S170]
  2. Istanbul University Research Fund [BAP-39729]

Ask authors/readers for more resources

Objective Our aim was to investigate the prevalence of neuronal autoantibodies (NAbs) in a large consecutive series with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) and to elucidate the clinical and laboratory clues for detection of NAbs in this prototype of frequent, drug-resistant epilepsy syndrome. Methods Consecutive patients diagnosed with MTLE fulfilling the MRI criteria for HS were enrolled. The sera of patients and various control groups (80 subjects) were tested for eight NAbs after ethical approval and signed consents. Brain tissues obtained from surgical specimens were also investigated by immunohistochemical analysis for the presence of inflammatory infiltrates. The features of seropositive versus seronegative groups were compared and binary logistic regression analysis was performed to explore the differentiating variables. Results We found antibodies against antigens, contactin-associated protein-like 2 in 11 patients, uncharacterised voltage-gated potassium channel (VGKC)-complex antigens in four patients, glycine receptor (GLY-R) in 5 patients, N-methyl-D-aspartate receptor in 4 patients and gamma-aminobutyric acid receptor A in 1 patient of 111 patients with MTLE-HS and none of the control subjects. The history of status epilepticus, diagnosis of psychosis and positron emission tomography or single-photon emission CT findings in temporal plus extratemporal regions were found significantly more frequently in the seropositive group. Binary logistic regression analysis disclosed that status epilepticus, psychosis and cognitive dysfunction were statistically significant variables to differentiate between the VGKC-complex subgroup versus seronegative group. Conclusions This first systematic screening study of various NAbs showed 22.5% seropositivity belonging mostly to VGKC-complex antibodies in a large consecutive series of patients with MTLE-HS. Our results indicated a VGKC-complex autoimmunity-related subgroup in the syndrome of MTLE-HS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy

Gunseli Orhun, Figen Esen, Vuslat Yilmaz, Canan Ulusoy, Elif Sanli, Elif Yildirim, Hakan Gurvit, Perihan Ergin Ozcan, Serra Sencer, Nerses Bebek, Erdem Tuzun

Summary: The study investigates whether neurofilament light chain (NFL) and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) could serve as prognostic biomarkers in sepsis-associated encephalopathy (SAE). The results show that serum and cerebrospinal fluid (CSF) levels of sTREM2 and NFL are associated with the severity of cognitive decline in SAE patients.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2023)

Article Clinical Neurology

Ictal Blinking: Reappraisal of the Lateralization and Localization Value in Focal Seizures

Ayse Nur Ozdag Acarli, Ayse Deniz Elmali, Nermin Gorkem Sirin, Betul Baykan, Nerses Bebek

Summary: Ictal blinking is a useful lateralizing sign in focal seizures, especially when it is unilateral or asymmetrical. It often appears early in the seizures and is associated with fronto-temporal seizure onset. However, symmetrical blinking does not seem to be valuable in lateralization and localization of focal seizures. Further studies using invasive recordings and periocular electrodes are needed to evaluate the value of blinking in lateralization and localization.

CLINICAL EEG AND NEUROSCIENCE (2023)

Article Clinical Neurology

Kv5.1 antibody in epilepsy patients with unknown etiology

Cem Ismail Kucukali, Busra Sengul, Duygu Gezen-Ak, Erdinc Dursun, Ece Erdag, Gurler Akpinar, Murat Kasap, Zerrin Karaaslan, Nermin Gorkem Sirin, Pinar Tekturk, Betul Baykan, Erdem Tuzun

Summary: A novel neuronal surface antibody to Kv5.1 was identified in patients with treatment-resistant epilepsy of unknown cause, suggesting a potential autoimmune etiology that requires further investigation.

EPILEPSY RESEARCH (2022)

Article Clinical Neurology

Do the neurologists recognize autoimmune epilepsy well enough? What is the effect of the pandemic on this matter?

Ebru Nur Vanli Yavuz, Ebru Altindag, Erdem Tuzun, Betul Baykan

Summary: This survey study on the attitudes of neurologists towards autoimmune epilepsy (AE) suggests that there is a relatively high level of awareness and understanding of AE, but there are still some deficiencies. Participants reported a lack of satisfactory guidelines for diagnosis and treatment, as well as widespread laboratory support. In addition, neurologists with less experience and those working outside of training hospitals tend to seek more consultation from experienced clinicians and conduct more detailed investigations.

NEUROLOGICAL SCIENCES (2022)

Article Clinical Neurology

Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences

Emanuele Cerulli Irelli, Enrico Cocchi, Georgia Ramantani, Roberto H. Caraballo, Loretta Giuliano, Tulay Yilmaz, Alessandra Morano, Eleni Panagiotakaki, Francesca F. Operto, Beatriz Gonzalez Giraldez, Katri Silvennoinen, Sara Casciato, Marion Comajuan, Simona Balestrini, Francesco Fortunato, Antonietta Coppola, Giancarlo Di Gennaro, Angelo Labate, Vito Sofia, Gerhard J. Kluger, Dorothee G. A. Kasteleijn-Nolst Trenite, Antonio Gambardella, Betul Baykan, Sanjay M. Sisodiya, Alexis Arzimanoglou, Pasquale Striano, Carlo Di Bonaventura

Summary: This study investigated electrodinical endophenotypes and long-term seizure outcome in patients with eyelid myoclonia with absences (EMA). The results showed that early epilepsy onset was the most relevant prognostic factor for poor treatment response. Additionally, two distinct endophenotypes were identified, EMA-plus and EMA-only, which differed in terms of remission rates and cognitive outcomes.

NEUROLOGY (2022)

Article Clinical Neurology

The effect of fear of COVID-19 on quality of life in patients with epilepsy

Kubra Yeni, Zeliha Tulek, Arif Ozer, Aysel Cavusoglu, Gorkem Sirin Inan, Betul Baykan, Nerses Bebek

Summary: This study examined the impact of COVID-19 fear on the quality of life in epilepsy patients, and found that fear increased anxiety and depression, ultimately leading to a decrease in quality of life.

NEUROLOGY ASIA (2022)

Article Medicine, Research & Experimental

Long-Term Prophylactic Transcranial Direct Current Stimulation Ameliorates Allodynia and Improves Clinical Outcomes in Individuals With Migraine

Serkan Aksu, Tuba Cerrahoglu Sirin, Buse Rahime Hasirci Bayir, Cagri Ulukan, Ahmet Zihni Soyata, Adnan Kurt, Sacit Karamursel, Betul Baykan

Summary: This study found that long-term extended transcranial direct current stimulation (tDCS) can effectively alleviate allodynia symptoms in migraine patients and meet the goals of prophylactic treatment.

NEUROMODULATION (2023)

Article Clinical Neurology

An Extraordinary EEG Phenomenon Misdiagnosed as Nonconvulsive Status Epilepticus: Frequent Subclinical Periodic Discharges Terminated by Sudden Auditory Stimuli

Emel Oguz-Akarsu, Baris Salman, Sibel Ugur-Iseri, Betul Baykan

Summary: This article reports a case of a 20-year-old woman with long-lasting bilateral paroxysmal high-voltage slow waves on EEG, which were interrupted by sudden verbal stimuli. Whole exome sequencing revealed potential genetic etiology. This rare manifestation of subclinical periodic discharges terminated by verbal stimuli deserves particular attention.

CLINICAL EEG AND NEUROSCIENCE (2023)

Article Clinical Neurology

Spectrum of epilepsy with eyelid myoclonia: Delineation of disease subtypes from a large multicenter study

Emanuele Cerulli Irelli, Enrico Cocchi, Georgia Ramantani, Antonella Riva, Roberto Horacio Caraballo, Alessandra Morano, Loretta Giuliano, Tulay Yilmaz, Eleni Panagiotakaki, Francesca F. Operto, Beatriz Gonzalez Giraldez, Simona Balestrini, Katri Silvennoinen, Sara Casciato, Marion Comajuan, Francesco Fortunato, Anna Teresa Giallonardo, Rimma Gamirova, Antonietta Coppola, Giancarlo Di Gennaro, Angelo Labate, Vito Sofia, Gerhard Josef Kluger, Antonio Gambardella, Dorothee G. A. Kasteleijn-NolstTrenite, Betul Baykan, Sanjay M. Sisodiya, Alexis Arzimanoglou, Pasquale Striano, Carlo Di Bonaventura

Summary: Based on age at epilepsy onset (AEO), this study identified three subtypes of objective epilepsy with eyelid myoclonia (EEM) and analyzed their distinct clinical features. Early onset EEM was associated with higher rates of intellectual disability, antiseizure medication refractoriness, and psychiatric comorbidities, while late onset EEM had the highest proportion of myoclonia involving body regions other than eyelids and generalized tonic-clonic seizures. Intermediate onset EEM had the lowest observed rate of additional findings. Family history of EEM was more frequent in the subtypes with intermediate and late onset. Patients with body-MYO showed higher rates of migraine and generalized tonic-clonic seizures.

EPILEPSIA (2023)

Article Clinical Neurology

Differential diagnosis of familial adult myoclonic epilepsy

Betul Baykan, Silvana Franceschetti, Laura Canafoglia, Gianpiero L. Cavalleri, Roberto Michelucci, Ingrid E. Scheffer

Summary: Familial adult myoclonic epilepsy (FAME) is a under-recognized disorder characterized by cortical myoclonus, generalized tonic-clonic seizures, and additional clinical symptoms, which vary depending on the FAME subtype. FAME is caused by pentanucleotide repeat expansions of intronic TTTCA/TTTTA in different genes.

EPILEPSIA (2023)

Article Immunology

Distribution of peripheral blood mononuclear cell subtypes in patients with West syndrome: Impact of synacthen treatment

Selen Soylu, Minara Cherkezzade, Ece Akbayir, Hande Yuceer Korkmaz, Gizem Koral, Elif Sanli, Pinar Topaloglu, Vuslat Yilmaz, Erdem Tuzun, Cem Ismail Kucukali

Summary: This study provides additional evidence for the involvement of inflammation in West Syndrome through immunophenotype analysis of peripheral blood. The results show that there are alterations in the proportions of certain immune cells in the peripheral blood of patients, but treatment with synthetic adrenocorticotropic hormone does not have a significant beneficial effect on most immune cells.

IMMUNOLOGY LETTERS (2023)

Article Clinical Neurology

Increased neuropil antibody prevalence in COVID-19 patients with acute ischemic stroke

Birgul Bastan, Ece Erdag Turgeon, Elif Sanli, Muhammet Duran Bayar, Aysel Busra Sisman, Miray Atacan Yasguclukal, Cem Ismail Kucukali, Erdem Tuzun, Sefer Gunaydin

Summary: This study investigated the presence and clinical impact of neuronal cell surface antibodies in patients with COVID-19 associated AIS. The results showed the existence of neuropil antibodies in COVID-19 patients, which may be associated with AIS and COVID-19. The antigenic targets and potential pathogenic action of these antibodies need further exploration.

NEUROLOGICAL RESEARCH (2023)

Article Clinical Neurology

The Ongoing Challenge of Diagnosing Non-convulsive Status Epilepticus: What About Generalized Non-reactive Rhythmic Alpha Activity in the Salzburg Criteria?

Irem Ilgezdi Kaya, Betuel Baykan

Summary: The ILAE Task Force on Classification released a report in 2015 to clarify the classification of status epilepticus. Non-convulsive status epilepticus (NCSE) was defined as SE without prominent motor symptoms, with or without coma. The increasing evidence in patients, who do not meet the Salzburg Consensus Criteria for NCSE diagnosis of 'NCSE' or 'possible NCSE', but whose clinical and electrophysiological features are still suspicious for NCSE, may pave the way for developing more comprehensive criteria. Therefore, we present here the 'generalized non-reactive alpha activity' in the electroencephalogram (EEG) of an elderly patient with no known epilepsy before, who presented with acute confusional state of unexplained cause, which we suspected as NCSE and managed accordingly with success. Considering that 'time is brain', early and correct NCSE diagnosis is critical and the NCSE EEG criteria should be more inclusive for the patients in the 'grey zone like the one presented here with 'generalized non-reactive alpha activity'.

ARCHIVES OF EPILEPSY (2023)

Letter Clinical Neurology

CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

Zerrin Karaaslan, Murat Kurtuncu, Halil Ibrahim Akcay, Tuncay Gunduz, Burcu Altunrende, Recai Turkoglu, Mefkure Eraksoy, Canan Ulusoy, Vuslat Yilmaz, Erdem Tuzun

EUROPEAN NEUROLOGY (2022)

No Data Available